Published in JAMA on January 17, 2001
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study. Bone (2014) 2.32
Osteoporosis: impact on health and economics. Nat Rev Rheumatol (2010) 2.25
Fracture risk following an osteoporotic fracture. Osteoporos Int (2003) 2.21
Influence of non-traumatic thoracic and lumbar vertebral fractures on sagittal spine alignment assessed by radiation-free spinometry. Osteoporos Int (2012) 2.17
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Safety and efficacy of vertebroplasty: Early results of a prospective one-year case series of osteoporosis patients in an academic high-volume center. Indian J Orthop (2009) 1.99
Complications of percutaneous vertebroplasty and their prevention. Skeletal Radiol (2004) 1.96
Efficacy and safety of balloon kyphoplasty in the treatment of vertebral compression fractures: a systematic review. Eur Spine J (2006) 1.96
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Which fractures are most attributable to osteoporosis? J Clin Epidemiol (2011) 1.84
The current treatment--a survey of osteoporotic fracture treatment. Osteoporotic spine fractures: the spine surgeon's perspective. Osteoporos Int (2004) 1.75
The risk and burden of vertebral fractures in Sweden. Osteoporos Int (2003) 1.74
Recommendations for preventing fracture in long-term care. CMAJ (2015) 1.62
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int (2005) 1.52
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int (2009) 1.47
The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population. Osteoporos Int (2003) 1.47
Build better bones with exercise: protocol for a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture. Phys Ther (2014) 1.44
Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int (2008) 1.42
UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos (2017) 1.40
The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int (2007) 1.40
The hospital cost of vertebral fractures in the EU: estimates using national datasets. Osteoporos Int (2003) 1.38
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. Clin Orthop Relat Res (2014) 1.38
One year outcomes and costs following a vertebral fracture. Osteoporos Int (2004) 1.37
Percutaneous vertebroplasty immediately relieves pain of osteoporotic vertebral compression fractures and prevents prolonged immobilization of patients. Eur Radiol (2004) 1.36
Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review. Eur Spine J (2006) 1.35
Refractures in cemented vertebrae after percutaneous vertebroplasty: a retrospective analysis. Eur Spine J (2008) 1.33
Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can (2006) 1.33
Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture. Osteoporos Int (2013) 1.33
Value of MRI imaging prior to a kyphoplasty for osteoporotic insufficiency fractures. Eur Spine J (2009) 1.30
Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial. Osteoporos Int (2007) 1.30
Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture. Osteoporos Int (2006) 1.30
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res (2012) 1.29
Back extensor strength and lumbar spinal mobility are predictors of quality of life in patients with postmenopausal osteoporosis. Osteoporos Int (2007) 1.28
Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat Rev Rheumatol (2012) 1.28
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int (2014) 1.27
The effect of osteoporotic vertebral fracture on predicted spinal loads in vivo. Eur Spine J (2006) 1.26
Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int (2005) 1.26
Another option to treat Kümmell's disease with cord compression. Eur Spine J (2006) 1.24
Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int (2007) 1.22
Evaluation and management of vertebral compression fractures. Perm J (2012) 1.22
Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures. Osteoporos Int (2014) 1.22
Back pain in osteoporotic vertebral fractures. Osteoporos Int (2007) 1.21
Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int (2006) 1.18
Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int (2010) 1.18
The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int (2005) 1.18
Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies. Eur Spine J (2012) 1.17
Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int (2003) 1.17
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17
Risk factors predicting the new symptomatic vertebral compression fractures after percutaneous vertebroplasty or kyphoplasty. Eur Spine J (2011) 1.17
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int (2004) 1.15
Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int (2004) 1.15
Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients. Eur Spine J (2006) 1.14
Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ (2009) 1.12
Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int (2010) 1.12
Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int (2004) 1.12
Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int (2008) 1.11
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J (2011) 1.11
Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures. Osteoporos Int (2011) 1.11
Epidemiology of fragility fractures in Italy. Clin Cases Miner Bone Metab (2011) 1.10
Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) (2012) 1.09
CT-guided vertebroplasty in osteoprotic vertebral fractures: incidence of secondary fractures and impact of intradiscal cement leakages during follow-up. Eur Radiol (2007) 1.09
Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int (2007) 1.08
Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08
Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int (2005) 1.07
Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study. Osteoporos Int (2015) 1.07
Rate and circumstances of clinical vertebral fractures in older men. Osteoporos Int (2007) 1.07
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int (2004) 1.07
Reporting of vertebral fractures on spine X-rays. Osteoporos Int (2005) 1.06
High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol (2012) 1.05
Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis. Osteoporos Int (2005) 1.04
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03
Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int (2004) 1.03
The orthopaedic surgeon's role in diagnosing and treating patients with osteoporotic fractures: standing discharge orders may be the solution for timely medical care. Osteoporos Int (2003) 1.03
Can Internet information on vertebroplasty be a reliable means of patient self-education? Clin Orthop Relat Res (2013) 1.03
Complications and safety aspects of kyphoplasty for osteoporotic vertebral fractures: a prospective follow-up study in 102 consecutive patients. Patient Saf Surg (2008) 1.02
Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women. Osteoporos Int (2006) 1.02
Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskelet Disord (2008) 1.02
Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep (2010) 1.01
Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis. BMC Palliat Care (2009) 1.01
An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int (2007) 1.01
Osteoporosis and skeletal fractures. HSS J (2006) 1.01
Transpedicle body augmenter in painful osteoporotic compression fractures. Eur Spine J (2006) 1.01
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res (2009) 1.00
Current status of percutaneous vertebroplasty and percutaneous kyphoplasty--a review. Med Sci Monit (2013) 1.00
Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trial. BMC Musculoskelet Disord (2010) 1.00
Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int (2011) 1.00
Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int (2003) 1.00
Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques. World J Radiol (2013) 0.99
Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. CMAJ (2002) 0.98
Osteoporosis and fracture risk in people with schizophrenia. Curr Opin Psychiatry (2012) 0.98
Transpedicle body augmenter for vertebral augmentation in symptomatic multiple osteoporotic compression fractures. Indian J Orthop (2010) 0.98
Safety of balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures in Europe: a meta-analysis of randomized controlled trials. Eur Spine J (2014) 0.97
Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications. Eur Radiol (2005) 0.97
Advances in bone imaging for osteoporosis. Nat Rev Endocrinol (2013) 0.97
Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis. Osteoporos Int (2012) 0.96
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Soliciting the patient's agenda: have we improved? JAMA (1999) 6.17
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Bone density screening for osteoporosis. Lancet (1990) 3.87
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int (2007) 3.50
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut (2004) 3.26
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
The bone density of female twins discordant for tobacco use. N Engl J Med (1994) 2.44
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 2.24
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23
Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19
Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) (2005) 2.11
Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health (1992) 2.11
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev (2006) 2.08
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Rheumatology (Oxford) (2007) 2.01
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab (2000) 2.00
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res (2003) 1.96
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Are rates of ageing determined in utero? Age Ageing (1998) 1.95
The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res (2002) 1.95
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing (1989) 1.94
[Osteoporosis in patients under oral anticoagulant treatment]. Dtsch Med Wochenschr (2004) 1.93
Lack of prediction in the motor behaviour of Parkinsonism. Brain (1978) 1.92
Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence? Osteoarthritis Cartilage (1993) 1.88
Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88
Studies on the role of the morphological constituents of the microsome fraction from rat liver in protein synthesis. Biochem J (1964) 1.86
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.85
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol (1998) 1.85